What is Supernus Pharmaceuticals's PEG ratio?

Supernus Pharmaceuticals (SUPN) reported PEG ratio of 0× in Q2 2025.

What is the long-term trend for Supernus Pharmaceuticals's PEG ratio?

Over 2 years (2020 to 2024), Supernus Pharmaceuticals's PEG ratio has grown at a -92.4% compound annual growth rate (CAGR), from 0.9× to 0×.

What does PEG ratio mean?

The P/E ratio divided by the trailing-twelve-month net-income growth rate (in percentage points). Adjusts the earnings multiple for the pace of earnings growth.

Supernus Pharmaceuticals SUPN PEG ratio

PEG ratio at other companies

Acadia PharmaceuticalsACAD

0.2×—

Catalyst PharmaceuticalCPRX

1.1×+1.1×

Neurocrine BiosciencesNBIX

0.2×—

Jazz PharmaceuticalsJAZZ

0.3×—

Collegium Pharmaceutical, Inc.COLL

0.2×—

Eli LillyLLY

0.3×-0.6×

Other financials

Income statement

See full

Revenue$207.7M+38.6%

Gross profit$184.3M+37.5%

Operating income-$8.3M+18.8%

Net income-$2.3M+80.6%

EPS (diluted)-$0.04+81.0%

Balance sheet

See full

Cash & equivalents$186.3M+60.8%

Total debt$40.9M+26.6%

Total equity$1.1B+4.5%

Total assets$1.5B+11.4%

Cash flow

See full

Operating cash flow$66.5M+117%

CapEx--100%

Free cash flow$66.5M+120%

Valuation

See full

Market cap$2.62B+43.7%

Enterprise value$2.47B+42.2%

P/S3.4×+0.6×

Profitability

See full

Gross margin89.4%+1.0pp

Operating margin-7.8%-18.9pp

Net margin-3.7%-13.0pp

FCF margin27.9%+3.4pp

Returns & leverage

See full

Return on equity-2.8%-9.1pp

Debt / equity0×0.0×

Current ratio2×-0.5×

Where this comes from

Calculated from Supernus Pharmaceuticals’s reported figures.

market cap/net income=0×

Based on the most recent quarter.

The official record: Supernus Pharmaceuticals’s 10-Q, filed August 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about Supernus Pharmaceuticals's peg ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Supernus Pharmaceuticals's PEG ratio?: Supernus Pharmaceuticals (SUPN) reported PEG ratio of 0× in Q2 2025.
What is the long-term trend for Supernus Pharmaceuticals's PEG ratio?: Over 2 years (2020 to 2024), Supernus Pharmaceuticals's PEG ratio has grown at a -92.4% compound annual growth rate (CAGR), from 0.9× to 0×.
What does PEG ratio mean?: The P/E ratio divided by the trailing-twelve-month net-income growth rate (in percentage points). Adjusts the earnings multiple for the pace of earnings growth.